Antonio Romero*, Luke Ashcraft, Aroop Chandra, Vincent DiMassa, Peadar Cremin, Scott E. Collibee, Chihyuan Chuang, James Hartman, Darren T. Hwee, David St. Jean, Justin Malinowski, Mikkel DeBenedetto, David C. Moebius, Joshua Payette, Richard Vargas, John Yeoman, Alykhan Motani, Jeffrey Reagan, Fady I. Malik and Bradley P. Morgan,
{"title":"更正“Nelutroctiv (CK-136)的发现,一种选择性心肌肌钙蛋白激活剂,用于治疗与心脏收缩力降低相关的心血管疾病”","authors":"Antonio Romero*, Luke Ashcraft, Aroop Chandra, Vincent DiMassa, Peadar Cremin, Scott E. Collibee, Chihyuan Chuang, James Hartman, Darren T. Hwee, David St. Jean, Justin Malinowski, Mikkel DeBenedetto, David C. Moebius, Joshua Payette, Richard Vargas, John Yeoman, Alykhan Motani, Jeffrey Reagan, Fady I. Malik and Bradley P. Morgan, ","doi":"10.1021/acs.jmedchem.4c0285010.1021/acs.jmedchem.4c02850","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"68 1","pages":"850 850"},"PeriodicalIF":6.8000,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/epdf/10.1021/acs.jmedchem.4c02850","citationCount":"0","resultStr":"{\"title\":\"Correction to “Discovery of Nelutroctiv (CK-136), a Selective Cardiac Troponin Activator for the Treatment of Cardiovascular Diseases Associated with Reduced Cardiac Contractility”\",\"authors\":\"Antonio Romero*, Luke Ashcraft, Aroop Chandra, Vincent DiMassa, Peadar Cremin, Scott E. Collibee, Chihyuan Chuang, James Hartman, Darren T. Hwee, David St. Jean, Justin Malinowski, Mikkel DeBenedetto, David C. Moebius, Joshua Payette, Richard Vargas, John Yeoman, Alykhan Motani, Jeffrey Reagan, Fady I. Malik and Bradley P. Morgan, \",\"doi\":\"10.1021/acs.jmedchem.4c0285010.1021/acs.jmedchem.4c02850\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":46,\"journal\":{\"name\":\"Journal of Medicinal Chemistry\",\"volume\":\"68 1\",\"pages\":\"850 850\"},\"PeriodicalIF\":6.8000,\"publicationDate\":\"2024-12-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://pubs.acs.org/doi/epdf/10.1021/acs.jmedchem.4c02850\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c02850\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c02850","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Correction to “Discovery of Nelutroctiv (CK-136), a Selective Cardiac Troponin Activator for the Treatment of Cardiovascular Diseases Associated with Reduced Cardiac Contractility”
期刊介绍:
The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents.
The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.